The Pharmaceutical Market: Cuba

Publication Date	February 2008
Publisher	Espicom
Product Type	Report
Pages	96
ISBN Number	not applicable
Product Code	ESP00001

Price

£595.00
approximately: $1,194 | €747

PDF

PRINT £595 ($1,194 | €747)

Order above formats by FAX

Summary

Cuba is one of the world's last unreconstructed communist countries. Under Dr Fidel Castro's Presidency, Cuba has attempted none of the economic reforms implemented in Eastern Europe or even China. With his brother Raul taking over the Presidency in February 2008 and with Fidel still acting as consultant to major decisions, it appears that political changes will be slow, if they happen. Despite this, the country has a reputation for the quality of its health services and health indicators, and has an impressive pharmaceutical/biotechnology research sector. This reputation is deserved in part, but conceals an ageing healthcare system in dire need of restructuring and modernising, none of which can be achieved without greatly increased funding.

During the Cold War, Cuba was a major Soviet ally, and the market remained largely closed to the West. During the 1990s, however, many countries in the West established links with Cuba. The USA, virtually alone, maintains its embargo against Cuba. This is starting to hurt US healthcare firms, as companies based in Asia, Canada and Western Europe have the high-tech market to themselves. The international healthcare industry is taking an increasing interest in Cuba, which in turn has made efforts to integrate into the global marketplace in an attempt to attract new funding for its healthcare system.

Since its realignment under the consortium QUIMEFA in 2001, domestic pharmaceutical production has kept growing, with increasing biotechnology export opportunities not only in developing countries but also in Europe and other developed countries. Cuba maintains a list of essential medicines (CBM - Cuadro Basico de Medicamentos), which contained 828 medicines in 2007, of which 525 are domestically produced. There is no commercial advertising in Cuba, instead advertising has an educational purpose. Cuba affords some level of pharmaceutical patent protection, although less than international norms. Since 2001, FARMACUBA has acted as importer, exporter and distributor for QUIMEFA.

Content

Background Data
- Geography
- Political Overview
- Economic Overview
  - Estimated/Projected GDP (PPP), 2004-13
- Population
  - Population, 1990-2006
  - Population by Province and Age Group, 2006
  - Population by Age Group, 2000-06 (%)
- Demographic Indicators
  - Principal Demographic Indicators, 1997-2006
- Mortality
  - Selected Causes of Death, 2002-06
  - Selected Causes of Death as % of Total, 2002-06
  - Rate/000 of Selected Causes of Death, 2002-06
  - Causes of Death, 2006
  - Infant Mortality
    - Infant Deaths by Selected Cause, 2000-06
- Morbidity
  - Incidence of Infectious Disease, 2000-06
  - Cancer Incidence
    - Cancer Incidence by Site, Males, 1999-2003
    - Cancer Incidence by Site, Females, 1999-2003
  - Vaccination
    - Vaccinations, Cuba, 1962-2006
- Charts
  - Map of Cuba
Healthcare System
- Organisation & Administration
- Health Expenditure
  - Estimated Health Expenditure, 2001-06 (US$ Billion)
  - Estimated Health Expenditure as % of GDP, 2001-06
  - Public Health Expenditure, 1990-2006
- Hospital Services
  - Hospital Resources
    - Hospitals by Province, 2000-06
    - Hospitals by Specialty, 2006
    - Hospital Beds by Province, 2001-06
    - Hospital Beds by Category, 2001-06
  - Intensive Care Units
  - Hospital Activity
    - Hospital Admissions, 1990-2006
    - ALOS, 2001-06 (Days)
    - Bed Occupancy by Specialty, 2001-06 (%)
  - Surgical Procedures
    - Operations Performed, 2001-06
- Ambulatory Care
  - Outpatient Facilities, 2002-06
  - Medical/Dental Consultations, 1990-2006
  - Medical Consultations by Sector, 2006
  - Medical Consultations by Sector, 2005
  - Civilian Medical Consultations by Therapeutic Area, 2001-06
- Medical Personnel
  - Physicians & Dentists, 1994-2006
  - Physicians & Dentists by Province, 2006
  - Physicians by Specialty, 2002-06
- Nursing Staff
  - Nursing Staff by Province, 2002-06
- Charts
  - Hospital Beds, 1990-2006
  - Hospital Admissions & Operations Performed, 1990-2006
Accessing The Pharmaceutical Market
- Introduction
- Regulatory Environment
  - Pharmaceutical Registration/ Drug Approval Process
    - Import Certificate Requests & Approvals, 2006
  - Registration of Antiretrovirals
    - Registered Antiretrovirals, 2000-2003
  - Advertising
  - Patent Protection & Intellectual Property Rights
  - Pricing & Reimbursement
- Distribution Channels
- Distributors
  - FARMACUBA
    - Leading Pharmaceutical Product Lines Distributed by FARMACUBA
- Trade Fairs
  - US-Cuba Healthcare Exhibition
  - Cubafarmacia
- Domestic Production
  - Pharmaceutical Production, 1997-2007 (Million Pesos)
  - List of Essential Medicines (CBM) by Sector & Origin, 2007
  - List of Essential Medicines (CBM) by Origin, 2007 (%)
  - Trade Associations
  - QUIMEFA
  - The Western Havana Bio-Cluster "Scientific Pole"
  - Domestic Producers
    - Leading Domestic Producers in Havana, 2003
  - Adalberto Pessant
  - CIDEM
  - CIGB (Heber Biotec)
    - CIGB?s Healthcare Product Lines, 2008
  - CIM (CIMAB)
  - Eron
  - Instituto FINLAY
  - MEDILIP
  - MEDSOL
  - NOVATEC
  - Reynaldo Gutirrez
  - Roberto Escudero Daz
  - 8 de Marzo
  - Foreign Producers
  - Bioven
  - Genesis Medical Technologies
  - GlaxoSmithKline
  - Research & Development
  - Clinical Trials
    - Clinical Trial Authorisations and Modifications by Product Type, Cumulative 1995-2006*
    - Processing Time for Clinical Trial Authorisations and Modifications, 2003-06
    - Clinical Trial Authorisations by Institution, 2001-2003
- Directory
  - Government Organisations
  - Trade Associations
- Charts
  - Drug Registrations, 1990-2007
  - Community Pharmacies, 1995-2006
  - Pharmaceutical Production, 1997-2007 (Million Pesos)